applying clinical symptoms ( bowel movements , registered by the patients on special charts ) , clinical condition ( assessed by the patient ) , proctoscopic signs , and registration of side effects , it is concluded that methyl-sasp had an effect on ulcerative colitis indistinguishable from that of sasp .
C0009324
ulcerative colitis
C0036078
sasp